Fibromyalgia: Combining Pharmacological and Nonpharmacological Approaches to Treating the Person, Not Just the Pain

Journal of Pain

Volumn 9, Issue 2, 2008, Pages 99-104

  Turk, Dennis C ^a   Vierck, Charles J ^a   Scarbrough, Elizabeth ^a   Crofford, Leslie J ^a   Rudin, Nathan J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; GABAPENTIN; MILNACIPRAN; OXYBATE SODIUM; OXYCODONE; PARACETAMOL; PLACEBO; PRAMIPEXOLE; PREGABALIN; TRAMADOL; VENLAFAXINE;

ADULT; ANALGESIA; ANAMNESIS; ARTICLE; BEHAVIOR THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DIZZINESS; EXERCISE; FATIGUE; FIBROMYALGIA; FOLLOW UP; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MASSAGE; META ANALYSIS; NEUROTRANSMISSION; NOCICEPTION; PAIN; PAIN ASSESSMENT; PARKINSON DISEASE; PERIPHERAL EDEMA; PHYSIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; SYSTEMATIC REVIEW;

ACCIDENTS, TRAFFIC; ADULT; FEMALE; FIBROMYALGIA; HUMANS; PAIN;

EID: 38349186390     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2007.08.006     Document Type: Article

References (37)

1. American College of Rheumatology Annual Meeting, Washington, DC, 2006
2. Angst F., Brioschi R., Main C.J., Lehmann S., and Aeschlimann A. Interdisciplinary rehabilitation in fibromyalgia and chronic back pain: A prospective outcome study. J Pain 7 (2006) 807-815
3. Arnold L.M., Goldenberg D.L., Stonfor S.B., Lalonde J.K., Sandhu H.S., Keck Jr. P.E., Welge J.A., Bishop F., Stanfor K.E., Hess E.V., and Hudson J.I. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 56 (2007) 1336-1344
4. Arnold L.M., Hess E.V., Hudson J.I., Welge J.A., Berno S.E., and Keck Jr. P.E. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 112 (2002) 191-197
5. Arnold L.M., Keck Jr. P.E., and Welge J.A. Antidepressant treatment of fibromyalgia: A meta-analysis and review. Psychosomatics 41 (2000) 104-113
6. Arnold L.M., Lu Y., Crofford L.J., Wohlreich M., Detke M.J., and Iyengar S. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50 (2004) 2974-2984
7. Arnold L.M., Rosen A., Pritchett Y.L., D'Souza D.N., Goldstein D.J., Iyengar S., and Wernicke J.F. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 119 (2005) 5-15
8. Barnsley L., and Bogduk N. Medial branch blocks are specific for the diagnosis of cervical zygapophyseal joint pain. Reg Anesth 18 (1993) 343-350
9. Barnsley L., Lord S.M., Wallis B.J., and Bogduk N. The prevalence of chronic cervical zygapophysial joint pain after whiplash. Spine 20 (1995) 20-26
10. Bennett R.M., Kamin M., Karim R., and Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: A double-blind, randomized, placebo-controlled study. Am J Med 114 (2003) 537-545
11. Burckhardt C., Goldenberg D.L., and Crofford L. Guideline for the Management of Fibromyalgia Syndrome Pain in Adults and Children (2005), American Pain Society, Chicago, IL
12. Carette S., Bell M.J., Reynolds W.J., Haraoui B., McCain G.A., Bykerk V.P., Edworthy S.M., Baron M., Koehler B.E., and Fam A.G. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: A randomized, double-blind clinical trial. Arthritis Rheum 37 (1994) 32-40
13. Crofford L.J., Rowbotham M.C., Mease P.J., Russell I.J., Dworkin R.H., Corbin A.E., Young Jr. J.P., LaMoreaux L.K., Martin S.A., and Sharma U. Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52 (2005) 1264-1273
14. Dinenno F.A., Eisenach J.H., Dietz N.M., and Joyner M.J. Post-junctional alpha-adrenoceptors and basal limb vascular tone in healthy men. J Physiol (Lond) 540 (2002) 1103-1110
15. Geisser M.E., Roth R.S., and Williams D.A. The allure of a cure. J Pain 7 (2006) 797-799
16. Glazer E.J., and Ross L.L. Localization of noradrenergic terminals in sympathetic preganglionic nuclei of the rat: Demonstration by immunocytochemical localization of dopamine-beta-hydroxylase. Brain Res 185 (1980) 39-49
17. Goldenberg D.L. Management of fibromyalgia syndrome. Rheum Dis Clin North Am 15 (1989) 499-512
18. Goldenberg D.L., Burckhardt C., and Crofford L. Management of fibromyalgia syndrome. JAMA 292 (2004) 2388-2395
19. Goldenberg D.L., Felson D.T., and Dinerman H. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 29 (1986) 1371-1377
20. Haeusler G. Central mechanisms in blood pressure regulation and hypertension. Int J Obes 5 suppl 1 (1981) 45-50
21. Holman A.J., and Myers R.R. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 52 (2005) 2495-2505
22. King C.D., Devine D.P., Vierck C.J., Rodgers J., and Yezierski R.P. Differential effects of stress on escape and reflex responses to nociceptive thermal stimuli in the rat. Brain Res 987 (2003) 214-222
23. Kiss A., and Aguilera G. Role of alpha-1-adrenergic receptors in the regulation of corticotropin-releasing hormone mRNA in the paraventricular nucleus of the hypothalamus during stress. Cell Mol Neurobiol 20 (2000) 683-694
24. Manchikanti L., Singh V., Rivera J., and Pampati V. Prevalence of cervical facet joint pain in chronic neck pain. Pain Physician 5 (2002) 243-249
25. Millan M.J. The neurobiology and control of anxious states. Prog Neurobiol 70 (2003) 83-244
26. O'Malley P.G., Balden E., Tomkins G., Santoro J., Kroenke K., and Jackson J.L. Treatment of fibromyalgia with antidepressants: A meta-analysis. J Gen Intern Med 15 (2000) 659-666
27. Pariante C.M., Thomas S.A., Lovestone S., Makoff A., and Kerwin R.W. Do antidepressants regulate how cortisol affects the brain?. Psychoneuroendocrinology 29 (2004) 423-447
28. Rosendal L., Larsson B., Kristiansen J., Peolsson M., Sogaard K., Kjaer M., Sorensen J., and Gerdle B. Increase in muscle nociceptive substances and anaerobic metabolism in patients with trapezius myalgia: Microdialysis in rest and during exercise. Pain 112 (2004) 324-334
29. Scharf M.B., Baumann M., and Berkowitz D.V. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol 30 (2003) 1070-1074
30. Tozawa Y., and Matsushima K. Peripheral 5-HT(2A)-receptor-mediated formation of an inhibitor of atrial natriuretic peptide binding involves inflammation. Eur J Pharmacol 440 (2002) 37-44
31. Turk D.C., Okifuji A., Sinclair J.D., and Starz T.W. Interdisciplinary treatment for fibromyalgia syndrome: Clinical and statistical significance. Arthritis Care Res 11 (1998) 186-195
32. Ulas U., Unlu E., Hamamcioglu K., Odabasi Z.C.A., and Vural O. Dysautonomia in fibromyalgia syndrome: Sympathetic skin responses and RR interval analysis. Rheumatol Int 26 (2005) 383-387
33. Vierck Jr. C.J. Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia). Pain 124 (2006) 242-263
34. Vitton O., Gendreau M., Gendreau J., Kranzler J., and Rao S.G. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol 19 Suppl 1 (2004) S27-S35
35. Wolfe F., Cathey M.A., and Hawley D.J. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 23 (1994) 255-259
36. Zhang L., Newman J.M., Richards S.M., Rattigan S., and Clark M.G. Microvascular flow routes in muscle controlled by vasoconstrictors. Microvasc Res 70 (2005) 7-16
37. Zijsltra T.R., Barendregt P.J., and van de Laar M.A. Venlafaxine in fibromyalgia: Results of a randomized placebo-controlled double blind trial [abstract]. Arthritis Rheum (2002) 26